MediciNova Inc. (MNOV)
NASDAQ: MNOV
· Real-Time Price · USD
1.33
0.03 (2.31%)
At close: Aug 15, 2025, 3:58 PM
1.33
0.00%
After-hours: Aug 15, 2025, 06:40 PM EDT
MediciNova Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -11.16M | -11.05M | -10.29M | -8.16M | -8.41M | -8.57M | -9.51M | -12.44M | -13.6M | -14.07M | -13.15M | -13.08M | -13.33M | -10.13M | -11.04M | -11.16M |
Depreciation & Amortization | 20.9K | 21.08K | 21.39K | 21.91K | 21.54K | 20.3K | 19.13K | 17.89K | 17.38K | 17.71K | 19.75K | 22.46K | 24.13K | 26.15K | 25.63K | 23.68K |
Stock-Based Compensation | 1.26M | 1.19M | 690.34K | 404.62K | 522.88K | 710.71K | 1.08M | 1.02M | 964.73K | 642.52K | -243.12K | 177.53K | 658.93K | 1.72M | 2.87M | 3.33M |
Other Working Capital | 748.33K | -667.21K | 383.26K | -660.62K | -149.75K | 92.75K | -1.72M | -789.58K | -475.11K | -699.05K | 344.48K | 138.11K | 3.67M | 83.89M | 83.67M | 83.61M |
Other Non-Cash Items | -1.09M | 1.18M | 838.36K | 842.54K | 855.46K | -49.38K | 282.63K | 262.95K | 270.04K | 163.19K | 182.63K | 318.03K | 303.93K | 1.4M | -168.01M | -168.87M |
Deferred Income Tax | n/a | n/a | 346.49K | 346.86K | 346.86K | 346.86K | 371.00 | n/a | n/a | n/a | 286.00 | 286.00 | 286.00 | 286.00 | 169.36M | 169.36M |
Change in Working Capital | 404.35K | -979.56K | 194.58K | -993.34K | -452.61K | 111.99K | -2.8M | -1.14M | -12.56K | 334.1K | 647.71K | -279.54K | 3.13M | -1.21M | 283.23K | -774.39K |
Operating Cash Flow | -10.56M | -10.64M | -9.21M | -8.55M | -8.12M | -7.43M | -10.94M | -12.29M | -12.36M | -12.91M | -12.54M | -12.84M | -9.26M | -9.38M | -7.69M | -8.58M |
Capital Expenditures | -895 | -895 | -875 | -3.61K | -21.3K | -21.3K | -26.33K | -23.59K | -5.01K | -5.01K | 2.94K | n/a | -25.79K | -25.79K | -61.43K | -59.68K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -4.99M | -4.99M | -4.99M | -4.99M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -49.88M | -59.88M | -59.88M | -59.88M | -10M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 39.89B | 39.89B | 39.89B | 39.93B | 59.81M | 59.81M | 59.81M | 19.88M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 198.00 | 198.00 | -21.3M | -21.3M | -21.3M | 18.63M | 44.92M | 34.92M | 34.92M | -5.01M | -38.71M | -28.71M | -28.71M | -28.71M | -36.49M | -36.49M |
Investing Cash Flow | -697 | -697 | -676 | -3.61K | -21.3K | 39.91M | 9.9M | -94.57K | -76K | -40.01M | -38.7M | -28.71M | -28.73M | -28.73M | -61.43K | -59.68K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 7.92K | 7.92K | 7.92K | 7.92K | n/a | n/a | -16 | -112.26K | -316.1K | -316.1K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 7.92K | 7.92K | 15.84K | 15.84K | 46.62K | 296.23K | 678.05K | 20.78M | 21.1M | 25.98M |
Net Cash Flow | -10.57M | -10.64M | -9.23M | -8.54M | -8.12M | 32.49M | -999.9K | -12.36M | -12.44M | -52.93M | -22.52M | -12.56M | -8.61M | 11.39M | 13.36M | 17.35M |
Free Cash Flow | -10.56M | -10.64M | -9.21M | -8.55M | -8.14M | -7.45M | -10.97M | -12.31M | -12.37M | -12.92M | -12.54M | -12.84M | -9.28M | -9.41M | -7.75M | -8.64M |